Chemical Structure (Nuplazid 01)
Nuplazid Capsule
Product Images NDC 63090-340
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Nuplazid (NDC 63090-340). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Acadia Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Nuplazid 02)
Figure 2 (Nuplazid 03)
Figure 3 (Nuplazid 04)
This appears to be a table or chart from a study comparing a medication called NUPLAZID to a placebo. The dosages cited are 34 mg. There seems to be a reference to a study week, and the rest of the text is not readable.*
Figure 4 (Nuplazid 05)
This appears to be a table showing the results of a treatment (NUPLAZID) compared to a placebo in terms of the percentage of patients who experienced improvement or worsening in their condition on a scale ranging from 1 to 10 points. The table shows the number of patients who experienced no change, improvement or worsening at each point on the scale. However, without additional context or information, it is difficult to determine what specific condition or illness is being treated.*
Figure 5 (Nuplazid 06)
Principal Display Panel (60 Tablets Bottle Label)
This is a product description for Nuplazid capsules by Acadia Pharmaceuticals Inc. It contains 34mg of pimavanserin and is prescribed for once a day use with or without food. The full prescribing information can be found in the package insert. The medication should be stored between 20-25°C, and away from children. Protect the medication from light to prevent potential capsule color fading. GTIN code and NDC code are also provided.*
Nuplazid 08
This is a medication distributed by Acadia Pharmaceuticals Inc. The tablet contains 10 mg of Pimavanserin tartrate, equivalent to 11.8 mg of Pimavanserin. The usual dosage instructions can be found in the package insert. The medication should be kept out of the reach of children and stored between 20°C to 25°C (68°F to 77°F). The prescription contains 30 tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
